Payers love digital technologies that reduce health costs and deliver patient benefit–but who should pick up the tab?
Digital technology is revolutionising healthcare from advanced electronic medical records and telemedicine to emerging technologies such as smart pills/inhalers and 3D dose printing. Great stuff, but payers are only interested in value. Where there is evidence that digital technology delivers lower costs by minimising hospitalisation, reducing waste and improving patient adherence and outcomes, then payers are on board. "Nice to have" technology, has no place. What does this mean for pharma? What digital technologies will influence payers? What role and contribution would payers like pharma to make?
To answer these key questions we interviewed eight US and European payer experts to reveal in Paying for Digital Health – Payer Insights the specific technologies, funding strategies and operational drivers that are shaping payer attitudes.
Payers explore the digital landscape
What payers say…
"Ultimately the payer is the one who says, 'I don't care how. I care what and when'… Whether it's a Proteus pill, a Wi-Fi-enabled injection or a Wi-Fi-enabled inhaler – those are all great things. Will they make a difference in the real world? And the companies want me to pay extra for it [but] I won't until they prove that it's better than what I have now. You're not in a risk-taking game, you're in the cost-reduction game… Maybe those who are paying step back and say, "Don't bamboozle me with technology. I'm in the business of buying value and giving value for money. What do you offer?"
Digital Health Expert
US
"I'm going to be a big sceptic here and say that 3D remote printing of medicine, robotic dispensing of printed medicine is a solution to a problem that I don't see."
Digital Health Expert
US
"If we have 100 patients that are eligible for a drug, our biggest concern is, how do we know all 100 patients are going to respond? Now, if there was a way with respect to some of these technologies [that] we're able to specifically identify the 20 we know are going to benefit and 80 we know are not, that's very beneficial because... that saves us 80 percent of the cost. I could definitely see where we could provide reimbursement if there was data showing that we were able to [target] utilisation of a product to a specific patient based on the technology."
Pharmacy Director
US
"One of the big things the pharma industry needs to pick up on is waste. We know by looking in anybody's bathroom cabinet, you've got boxes of unused pills, often reaching expiry date, often for people with multiple comorbidities who will have reams and reams of this, and they get their repeat prescriptions. That model can't survive. It's got to be about making sure that people are being compliant with their meds. Smart pills are one of the ways of monitoring that, ensuring that the drugs that are prescribed are actually having value."
US Payer
What to expect
Expert contributors
The report harnesses critical frontline insights from senior payers who completely understand how digital technology can support them, and presents their views on how it can be funded. To ensure frank and open opinions were expressed we have agreed to keep their identities anonymous.
Why Choose FirstWord?
Are you fed up with management reports that over-promise and under-deliver? Reports packed out with secondary research and uncorroborated content? If this is your experience, then turn to FirstWord because…
All Contents Copyright © 2021 Doctor's Guide Publishing Limited All Rights Reserved